KRRO

Korro Bio, Inc. Common Stock

13.37

USD

KRRO Earnings Reports

Positive Surprise Ratio

KRRO beat 13 of 25 last estimates.

52%

Next Report

Date of Next Report

Mar 16, 2026

Estimate for Q4 25 (Revenue/ EPS)

$607.47K

-$2.07

Implied change from Q3 25 (Revenue/ EPS)

-44.27%

+7.81%

Implied change from Q4 24 (Revenue/ EPS)

-73.25%

-8.00%

Korro Bio, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, KRRO reported earnings of -1.92 USD per share (EPS) for Q3 25, beating the estimate of -2.64 USD, resulting in a 27.43% surprise. Revenue reached 1.09 million, compared to an expected 589.78 thousand, with a 84.81% difference. The market reacted with a -79.31% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 12 analysts forecast an EPS of -2.07 USD, with revenue projected to reach 607.47 thousand USD, implying an increase of 7.81% EPS, and decrease of -44.27% in Revenue from the last quarter.

FAQ

What were Korro Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Korro Bio, Inc. Common Stock reported EPS of -$1.92, beating estimates by 27.43%, and revenue of $1.09M, 84.81% above expectations.

How did the market react to Korro Bio, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -79.31%, changed from $31.42 before the earnings release to $6.50 the day after.

When is Korro Bio, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 16, 2026.

What are the forecasts for Korro Bio, Inc. Common Stock's next earnings report?

Based on 12 analysts, Korro Bio, Inc. Common Stock is expected to report EPS of -$2.07 and revenue of $607.47K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.